FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048308909> ?p ?o ?g. }

• W2048308909 abstract "Antibiotic treatment of tularaemia is based on a few drugs, including the fluoroquinolones (e.g., ciprofloxacin), the tetracyclines (e.g., doxycycline), and the aminoglycosides (streptomycin and gentamicin). Because no effective and safe vaccine is currently available, tularaemia prophylaxis following proven exposure to F. tularensis also relies on administration of antibiotics. A number of reasons make it necessary to search for new therapeutic alternatives: the potential toxicity of first-line drugs, especially in children and pregnant women; a high rate of treatment relapses and failures, especially for severe and/or suppurated forms of the disease; and the possible use of antibiotic-resistant strains in the context of a biological threat. This review presents novel therapeutic approaches that have been explored in recent years to improve tularaemia patients' management and prognosis. These new strategies have been evaluated in vitro, in axenic media and cell culture systems and/or in animal models. First, the activities of newly available antibiotic compounds were evaluated against F. tularensis, including tigecycline (a glycylcycline), ketolides (telithromycin and cethromycin), and fluoroquinolones (moxifloxacin, gatifloxacin, trovafloxacin and grepafloxacin). The liposome delivery of some antibiotics was evaluated. The effect of antimicrobial peptides against F. tularensis was also considered. Other drugs were evaluated for their ability to suppress the intracellular multiplication of F. tularensis. The effects of the modulation of the innate immune response (especially via TLR receptors) on the course of F. tularensis infection was characterized. Another approach was the administration of specific antibodies to induce passive resistance to F. tularensis infection. All of these studies highlight the need to develop new therapeutic strategies to improve the management of patients with tularaemia. Many possibilities exist, some unexplored. Moreover, it is likely that new therapeutic alternatives that are effective against this intracellular pathogen could be, at least partially, extrapolated to other human pathogens." @default.
• W2048308909 created "2016-06-24" @default.
• W2048308909 creator A5002265993 @default.
• W2048308909 creator A5053964411 @default.
• W2048308909 creator A5062890238 @default.
• W2048308909 creator A5079728048 @default.
• W2048308909 date "2014-03-28" @default.
• W2048308909 modified "2023-10-05" @default.
• W2048308909 title "New therapeutic approaches for treatment of tularaemia: a review" @default.
• W2048308909 cites W1578857830 @default.
• W2048308909 cites W1656916634 @default.
• W2048308909 cites W1947578056 @default.
• W2048308909 cites W1959087976 @default.
• W2048308909 cites W1965053142 @default.
• W2048308909 cites W1967687261 @default.
• W2048308909 cites W1970506798 @default.
• W2048308909 cites W1973721364 @default.
• W2048308909 cites W1975239204 @default.
• W2048308909 cites W1981349153 @default.
• W2048308909 cites W1997422898 @default.
• W2048308909 cites W2002045810 @default.
• W2048308909 cites W2004092704 @default.
• W2048308909 cites W2010008731 @default.
• W2048308909 cites W2013740360 @default.
• W2048308909 cites W2020435454 @default.
• W2048308909 cites W2025880445 @default.
• W2048308909 cites W2032858523 @default.
• W2048308909 cites W2032894124 @default.
• W2048308909 cites W2033410574 @default.
• W2048308909 cites W2042316145 @default.
• W2048308909 cites W2051354982 @default.
• W2048308909 cites W2054330479 @default.
• W2048308909 cites W2062218945 @default.
• W2048308909 cites W2070325209 @default.
• W2048308909 cites W2071846790 @default.
• W2048308909 cites W2071963282 @default.
• W2048308909 cites W2079945320 @default.
• W2048308909 cites W2082466940 @default.
• W2048308909 cites W2088652385 @default.
• W2048308909 cites W2093273508 @default.
• W2048308909 cites W2094823810 @default.
• W2048308909 cites W2096995152 @default.
• W2048308909 cites W2108551457 @default.
• W2048308909 cites W2109398861 @default.
• W2048308909 cites W2120335030 @default.
• W2048308909 cites W2121019553 @default.
• W2048308909 cites W2124260959 @default.
• W2048308909 cites W2124279100 @default.
• W2048308909 cites W2126460665 @default.
• W2048308909 cites W2131148090 @default.
• W2048308909 cites W2138092843 @default.
• W2048308909 cites W2138558388 @default.
• W2048308909 cites W2141066876 @default.
• W2048308909 cites W2141680921 @default.
• W2048308909 cites W2147453764 @default.
• W2048308909 cites W2149779601 @default.
• W2048308909 cites W2150699107 @default.
• W2048308909 cites W2151399550 @default.
• W2048308909 cites W2151432926 @default.
• W2048308909 cites W2152782544 @default.
• W2048308909 cites W2154899109 @default.
• W2048308909 cites W2157648447 @default.
• W2048308909 cites W2158320933 @default.
• W2048308909 cites W2161513080 @default.
• W2048308909 cites W2163440400 @default.
• W2048308909 cites W2164128280 @default.
• W2048308909 cites W2170394807 @default.
• W2048308909 cites W252634188 @default.
• W2048308909 cites W4211067865 @default.
• W2048308909 cites W4211198655 @default.
• W2048308909 cites W4294155569 @default.
• W2048308909 doi "https://doi.org/10.3389/fcimb.2014.00040" @default.
• W2048308909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3975101" @default.
• W2048308909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24734221" @default.
• W2048308909 hasPublicationYear "2014" @default.
• W2048308909 type Work @default.
• W2048308909 sameAs 2048308909 @default.
• W2048308909 citedByCount "53" @default.
• W2048308909 countsByYear W20483089092014 @default.
• W2048308909 countsByYear W20483089092015 @default.
• W2048308909 countsByYear W20483089092016 @default.
• W2048308909 countsByYear W20483089092017 @default.
• W2048308909 countsByYear W20483089092018 @default.
• W2048308909 countsByYear W20483089092019 @default.
• W2048308909 countsByYear W20483089092020 @default.
• W2048308909 countsByYear W20483089092021 @default.
• W2048308909 countsByYear W20483089092022 @default.
• W2048308909 countsByYear W20483089092023 @default.
• W2048308909 crossrefType "journal-article" @default.
• W2048308909 hasAuthorship W2048308909A5002265993 @default.
• W2048308909 hasAuthorship W2048308909A5053964411 @default.
• W2048308909 hasAuthorship W2048308909A5062890238 @default.
• W2048308909 hasAuthorship W2048308909A5079728048 @default.
• W2048308909 hasBestOaLocation W20483089091 @default.
• W2048308909 hasConcept C2777179404 @default.
• W2048308909 hasConcept C501593827 @default.
• W2048308909 hasConcept C71924100 @default.
• W2048308909 hasConcept C86803240 @default.
• W2048308909 hasConcept C89423630 @default.
• W2048308909 hasConcept C98274493 @default.

• next